相似文献
1
Detection of drug-sensitizing EGFR exon 19 deletion mutations in salivary gland carcinoma.
Br J Cancer. 2008 Jul 8;99(1):90-2. doi: 10.1038/sj.bjc.6604430. Epub 2008 Jun 10.
2
Acquired resistance to epidermal growth factor receptor kinase inhibitors associated with a novel T854A mutation in a patient with EGFR-mutant lung adenocarcinoma.
Clin Cancer Res. 2008 Nov 15;14(22):7519-25. doi: 10.1158/1078-0432.CCR-08-0151.
3
Prediction of sensitivity to gefitinib/erlotinib for EGFR mutations in NSCLC based on structural interaction fingerprints and multilinear principal component analysis.
BMC Bioinformatics. 2018 Mar 7;19(1):88. doi: 10.1186/s12859-018-2093-6.
4
Comparison of clinical outcomes following gefitinib and erlotinib treatment in non-small-cell lung cancer patients harboring an epidermal growth factor receptor mutation in either exon 19 or 21.
J Thorac Oncol. 2014 Apr;9(4):506-11. doi: 10.1097/JTO.0000000000000095.
5
Differential responses to erlotinib in epidermal growth factor receptor (EGFR)-mutated lung cancers with acquired resistance to gefitinib carrying the L747S or T790M secondary mutations.
J Clin Oncol. 2008 Mar 1;26(7):1182-4; author reply 1184-6. doi: 10.1200/JCO.2007.14.9039.
6
Erlotinib in symptomatic brain metastases from a lung adenocarcinoma with a sensitizing EGFR mutation.
J Thorac Oncol. 2012 Jun;7(6):1059-60. doi: 10.1097/JTO.0b013e31824cc34a.
7
Impact of cigarette smoking on response to epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors in lung adenocarcinoma with activating EGFR mutations.
Lung Cancer. 2014 May;84(2):196-202. doi: 10.1016/j.lungcan.2014.01.022. Epub 2014 Feb 3.
8
EGFR mutation L747P led to gefitinib resistance and accelerated liver metastases in a Chinese patient with lung adenocarcinoma.
Int J Clin Exp Pathol. 2015 Jul 1;8(7):8603-6. eCollection 2015.
9
EGFR and KRAS mutations as criteria for treatment with tyrosine kinase inhibitors: retro- and prospective observations in non-small-cell lung cancer.
Ann Oncol. 2007 Jan;18(1):99-103. doi: 10.1093/annonc/mdl323. Epub 2006 Oct 23.
10
Salivary gland-type lung carcinomas: an EGFR immunohistochemical, molecular genetic, and mutational analysis study.
Mod Pathol. 2008 Sep;21(9):1168-75. doi: 10.1038/modpathol.2008.113. Epub 2008 Jun 27.
引用本文的文献
1
Clinical use of F-FDG PET/CT in the differential diagnosis of patients with primary and secondary adenoid cystic carcinoma of the lung: a retrospective cohort study.
Transl Lung Cancer Res. 2022 Aug;11(8):1643-1656. doi: 10.21037/tlcr-22-509.
2
Bronchial mucoepidermoid carcinoma: A case report.
Int J Surg Case Rep. 2017;31:159-162. doi: 10.1016/j.ijscr.2017.01.042. Epub 2017 Jan 19.
3
Molecular genetic studies on EGFR, KRAS, BRAF, ALK, PIK3CA, PDGFRA, and DDR2 in primary pulmonary adenoid cystic carcinoma.
Diagn Pathol. 2015 Sep 15;10:161. doi: 10.1186/s13000-015-0409-7.
4
High-throughput profiling identifies clinically actionable mutations in salivary duct carcinoma.
J Transl Med. 2014 Oct 25;12:299. doi: 10.1186/s12967-014-0299-6.
5
Phase II study of gefitinib in patients with advanced salivary gland cancers.
Head Neck. 2015 May;37(5):644-9. doi: 10.1002/hed.23647. Epub 2015 Mar 30.
6
Aberrations in the epidermal growth factor receptor gene in 958 patients with diverse advanced tumors: implications for therapy.
Ann Oncol. 2013 Mar;24(3):838-42. doi: 10.1093/annonc/mds524. Epub 2012 Nov 8.
7
Activation of the EGFR/ERK pathway in high-grade mucoepidermoid carcinomas of the salivary glands.
Br J Cancer. 2010 Aug 10;103(4):510-6. doi: 10.1038/sj.bjc.6605788. Epub 2010 Jul 27.
8
Unfavorable prognosis of CRTC1-MAML2 positive mucoepidermoid tumors with CDKN2A deletions.
Genes Chromosomes Cancer. 2010 Jan;49(1):59-69. doi: 10.1002/gcc.20719.
9
Epidermal growth factor receptor kinase domain mutations are rare in salivary gland carcinomas.
Br J Cancer. 2009 Feb 24;100(4):623-5. doi: 10.1038/sj.bjc.6604875. Epub 2009 Jan 27.
本文引用的文献
1
Two allele-specific PCR assays for screening epidermal growth factor receptor gene hotspot mutations in lung adenocarcinoma.
Mol Med Rep. 2008 Jan-Feb;1(1):45-50.
2
Phase II study of lapatinib in recurrent or metastatic epidermal growth factor receptor and/or erbB2 expressing adenoid cystic carcinoma and non adenoid cystic carcinoma malignant tumors of the salivary glands.
J Clin Oncol. 2007 Sep 1;25(25):3978-84. doi: 10.1200/JCO.2007.11.8612.
3
Epidermal growth factor receptor mutations in lung cancers.
Pathol Int. 2007 May;57(5):233-44. doi: 10.1111/j.1440-1827.2007.02098.x.
4
Recent advances in the treatment of salivary gland cancers: emphasis on molecular targeted therapy.
Oral Oncol. 2007 Sep;43(8):729-34. doi: 10.1016/j.oraloncology.2006.12.012. Epub 2007 Mar 9.
5
Exon 19 deletion mutations of epidermal growth factor receptor are associated with prolonged survival in non-small cell lung cancer patients treated with gefitinib or erlotinib.
Clin Cancer Res. 2006 Jul 1;12(13):3908-14. doi: 10.1158/1078-0432.CCR-06-0462.
6
Clinical course of patients with non-small cell lung cancer and epidermal growth factor receptor exon 19 and exon 21 mutations treated with gefitinib or erlotinib.
Clin Cancer Res. 2006 Feb 1;12(3 Pt 1):839-44. doi: 10.1158/1078-0432.CCR-05-1846.
7
Rapid polymerase chain reaction-based detection of epidermal growth factor receptor gene mutations in lung adenocarcinomas.
J Mol Diagn. 2005 Aug;7(3):396-403. doi: 10.1016/S1525-1578(10)60569-7.
8
Mutations in the epidermal growth factor receptor and in KRAS are predictive and prognostic indicators in patients with non-small-cell lung cancer treated with chemotherapy alone and in combination with erlotinib.
J Clin Oncol. 2005 Sep 1;23(25):5900-9. doi: 10.1200/JCO.2005.02.857. Epub 2005 Jul 25.
9
EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy.
Science. 2004 Jun 4;304(5676):1497-500. doi: 10.1126/science.1099314. Epub 2004 Apr 29.
10
Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib.
N Engl J Med. 2004 May 20;350(21):2129-39. doi: 10.1056/NEJMoa040938. Epub 2004 Apr 29.
Zotero 插件